Retracted Article: Chrysin attenuates myocardial ischemia-reperfusion injury by inhibiting myocardial inflammation

Area of Science:

• Cardiology
• Biochemistry
• Pharmacology

Background:

• Myocardial ischemia-reperfusion (I/R) injury is a significant clinical problem.
• Inflammation plays a key role in the pathogenesis of I/R injury.
• Chrysin (CH) is a natural flavonoid with potential anti-inflammatory properties.

Purpose of the Study:

• To investigate the protective effects of Chrysin (CH) against myocardial ischemia-reperfusion (I/R) injury.
• To explore the underlying anti-inflammatory mechanisms of CH in cardiac I/R injury.

Main Methods:

• Coronary artery occlusion and reperfusion model in rats.
• Hypoxia/reoxygenation (H/R) model using H9C2 cardiac cells.
• Measurement of cardiac injury markers (ST segment, TTC staining, pathological analysis).
• Assessment of inflammatory cytokines and the HMGB1 signaling pathway.

Main Results:

• Chrysin (CH) significantly alleviated myocardial injury in both rat models and H9C2 cells.
• CH treatment led to the restoration of the ST segment in rats.
• CH reduced the levels of pro-inflammatory cytokines and suppressed the HMGB1-related inflammation pathway.

Conclusions:

• Chrysin (CH) exhibits significant cardioprotective effects against ischemia-reperfusion injury.
• The protective mechanisms of CH involve the suppression of inflammatory pathways, particularly the HMGB1 pathway.
• CH holds promise as a therapeutic agent for managing myocardial I/R injury.